.Basilea Pharmaceutica's job cultivating brand new antifungals has gotten a considerable boost from ...
.Possessing already gathered up the USA legal rights to Capricor Rehabs' late-stage Duchenne muscle ...
.After pushing the selection date for Applied Rehabs' metabolic condition medicine govorestat, the F...
.Novo Nordisk is continuing its press right into hereditary medications, consenting to pay NanoVatio...
.Innovent Biologics has produced the instance that its gate inhibitor-cytokine fusion protein posses...
.A stage 3 test of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) h...
.5 months after Rakovina Therapies turned toward expert system, the cancer-focused biotech has actua...
.Ascendis Pharma has actually emerged as a possible threat to BioMarin's Voxzogo, reporting phase 3 ...
.Though Alkeus Pharmaceuticals' dental eye disease property failed to substantially lower geographic...
.Along with a triad of biotechs striking the Nasdaq on Friday, it was very easy to overlook a smalle...
.Immune checkpoint inhibitors are the superheroes of cancer cells therapy. Medications like Bristol ...
.Accept to recently's Chutes & Ladders, our summary of notable leadership hirings, shootings and ...
.Regeneron is back along with long-term follow-up for its own LAG-3 inhibitor as well as PD-1 preven...
.AstraZeneca has actually discussed a very early examine the performance of its own internal antibod...
.After declaring a period 3 launch based upon favorable midstage outcomes, iTeos as well as GSK are ...
.The FDA should be much more open as well as collective to let loose a surge in commendations of unu...
.It's an abnormally busy Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Rehabs...
.Atea Pharmaceuticals' antiviral has actually neglected one more COVID-19 trial, however the biotech...
.Neurocrine Biosciences' schizophrenia system pivot has neglected. The biotech was actually not able...
.Sanofi has brought in an overdue access to the radioligand celebration, paying out one hundred mill...